Clinical Trial Update: A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Gemcitabine with and without IMM-101 in advanced pancreatic cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• IMM 101

Snippet

Sponsor: Immodulon Therapeutics Ltd | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-29